Janux Therapeutics JANX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Janux Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Janux Therapeutics's asset turnover?
- Janux Therapeutics (JANX) reported asset turnover of 0× in Q1 2026.
- How has Janux Therapeutics's asset turnover changed year-over-year?
- Janux Therapeutics's asset turnover increased by 23.4% year-over-year, from 0× to 0×.
- What is the long-term trend for Janux Therapeutics's asset turnover?
- Over 4 years (2021 to 2025), Janux Therapeutics's asset turnover has grown at a -14.8% compound annual growth rate (CAGR), from 0× to 0×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.